Core Viewpoint - Sichuan Shuangma (000935.SZ) announced that its subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. successfully passed an on-site inspection by the Russian Federal Service for Surveillance in Healthcare, receiving the GMP certificate from the Ministry of Industry and Trade of the Russian Federation [1] Group 1 - The on-site inspection took place from July 30 to August 1, 2025 [1] - The successful acquisition of the GMP certificate confirms compliance with the Eurasian Economic Union's Good Manufacturing Practice standards [1]

Core Points - Sichuan Shuangma's subsidiary, Hubei Jianxiang Biopharmaceutical Co., Ltd., successfully passed an on-site inspection conducted by the Russian Federal Service for Surveillance in Healthcare from July 30 to August 1, 2025 [1] - The company received the "Good Manufacturing Practice Compliance Certificate" issued by the Russian Federal Ministry of Industry and Trade, confirming compliance with the Eurasian Economic Union's pharmaceutical production standards [1]

证券代码：000935 证券简称：四川双马 公告编号：2025-44 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 四川和谐双马股份有限公司（以下简称"公司"）控股子公司湖北健翔生物 制药有限公司（以下简称"湖北健翔"）于 2025 年 7 月 30 日至 2025 年 8 月 1 日接受了俄罗斯联邦工业和贸易部下属国家药品检查机构的现场检查。近日，公 司收到俄罗斯联邦工业和贸易部签发的《欧亚经济联盟药品良好生产规范符合性 证书》（以下简称"GMP 证书"），确认湖北健翔顺利通过该次检查。现将相 关情况公告如下： 一、本次 GMP 现场检查的相关情况 1、企业名称：湖北健翔生物制药有限公司 2、检查地址：湖北咸宁咸安经济开发区绿山路 9 号 4、检查范围：药品生产质量管理规范检查，范围涵盖药品质量体系、生产 体系、质量控制、人员管理、公用系统、厂房与设备等核心环节，产品涉及替尔 泊肽原料药。 四川和谐双马股份有限公司 关于控股子公司湖北健翔获得俄罗斯 GMP 证书的公告 3、检查报告编号：No 1565/50533/19-25 5、检查时间：2025 年 7 ...

Core Viewpoint - Sichuan Shuangma (000935) is actively advancing its strategic layout this year, focusing on market expansion, core product R&D innovation, and optimizing cost management across the entire chain [1] Group 1: Strategic Initiatives - The company is committed to deepening the exploration of potential market opportunities [1] - Emphasis is placed on refined management to enhance operational efficiency and overall management levels [1] Group 2: Performance Outlook - The company aims to deliver excellent performance to reward its investors [1] - Investors are encouraged to pay attention to the company's upcoming announcements regarding specific performance details [1]

Core Viewpoint - Sichuan Shuangma (000935) emphasizes its commitment to serving national strategies and the real economy, focusing on developing new productive forces and identifying high-growth potential industries and innovative sectors [1] Group 1 - The company is actively engaged in nurturing and cultivating several high-quality enterprises [1] - The goal is to create sustained value for shareholders [1]

Core Viewpoint - The company emphasizes a commitment to steady development and refined management, focusing on strengthening its investment management and private equity fund management business [1] Group 1 - The company aims to enhance communication and interaction with fund investors to improve service quality [1] - The goal is to increase investor trust and recognition, contributing to the company's long-term stable development [1]

Group 1 - The company responded to an investor inquiry regarding its stake in Chery Automobile and the associated cost [2] - Sichuan Shuangma indicated that the funds it invested in are related to the automotive manufacturing industry, and relevant information should be based on public disclosures [2]

Group 1 - Sichuan Shuangma's stock price increased by 5.02% to 20.91 CNY per share, with a trading volume of 89.93 million CNY and a turnover rate of 0.57%, resulting in a total market capitalization of 15.964 billion CNY [1] - Sichuan Shuangma was established on October 20, 1998, and listed on August 24, 1999. The company operates in the building materials industry and private equity fund investment management [1] - The revenue composition of Sichuan Shuangma includes private equity fund management at 33.36%, cement at 32.46%, biomedicine at 23.08%, and aggregates at 11.10% [1] Group 2 - E Fund's ETF, the E Fund CSI All Share Building Materials ETF (159787), holds 74,700 shares of Sichuan Shuangma, accounting for 2.44% of the fund's net value, ranking as the tenth largest holding [2] - The E Fund CSI All Share Building Materials ETF was established on March 4, 2022, with a current size of 55.7768 million CNY. It has achieved a year-to-date return of 10.63% and a one-year return of 35.91% [2] - The fund has a cumulative loss of 29.56% since its inception [2] Group 3 - The fund manager of E Fund CSI All Share Building Materials ETF is Song Zhaoxian, who has been in the position for 5 years and 6 days, managing total assets of 28.905 billion CNY [3] - During his tenure, the best fund return was 77.65%, while the worst return was -47.14% [3]

Core Viewpoint - The diversified financial sector experienced a rise of 1.61% on September 5, with Sichuan Shuangma leading the gains [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3812.51, up 1.24% [1] - The Shenzhen Component Index closed at 12590.56, up 3.89% [1] Group 2: Individual Stock Performance - Sichuan Shuangma (000935) closed at 19.58, with a gain of 5.27% and a trading volume of 155,600 shares, totaling a transaction value of 300 million yuan [1] - Bohai Leasing (000415) closed at 3.51, up 2.93%, with a trading volume of 912,600 shares and a transaction value of 316 million yuan [1] - Electric Power Investment and Financing (000958) closed at 6.68, also up 2.93%, with a trading volume of 413,200 shares and a transaction value of 272 million yuan [1] - Hainan Huatie (603300) closed at 10.17, up 2.83%, with a trading volume of 750,700 shares and a transaction value of 755 million yuan [1] - COFCO Capital (002423) closed at 13.38, up 2.69%, with a trading volume of 559,000 shares and a transaction value of 741 million yuan [1] - Jiuding Investment (600053) closed at 17.42, up 2.65%, with a trading volume of 64,800 shares and a transaction value of 111 million yuan [1] - Haide Shares (000567) closed at 6.40, up 2.40%, with a trading volume of 154,100 shares and a transaction value of 97.25 million yuan [1] - Huachuang Capital (000532) closed at 15.01, up 2.32%, with a trading volume of 74,000 shares and a transaction value of 110 million yuan [1] - Yong'an Futures (600927) closed at 15.16, up 2.23%, with a trading volume of 94,400 shares and a transaction value of 142 million yuan [1] - State Grid Yingda (600517) closed at 5.73, up 1.96%, with a trading volume of 282,800 shares and a transaction value of 160 million yuan [1] Group 3: Capital Flow - The diversified financial sector saw a net inflow of 323 million yuan from main funds, while retail funds experienced a net outflow of 101 million yuan [1] - Speculative funds had a net outflow of 222 million yuan [1]

Core Insights - The company experienced significant growth in H1 2025, primarily due to a turnaround in investment income and revenue from the acquisition of Shenzhen JianYuan in the pharmaceutical sector [1][2]. Financial Performance - Adjusted revenue and net profit for H1 2025 were 665 million and 129 million yuan, respectively, reflecting year-on-year increases of 65% and 13% [2]. - Investment income, including investment gains and fair value changes, reached 36 million yuan, recovering from a negative 79 million yuan in the same period of 2024 [2]. - Private equity management fee income decreased by 5.07% to 210 million yuan, while revenue from the building materials segment grew by 4.88% to 274 million yuan [2]. - Revenue from the biopharmaceutical segment was 145 million yuan, driven by the acquisition of Shenzhen JianYuan, which contributed to both business and investment income growth [2]. Strategic Moves - The acquisition of Shenzhen JianYuan represents a deepened commitment to the biopharmaceutical industry, focusing on the research and sales of peptide products, which is expected to drive future revenue growth [3]. - The company is also looking to enhance its project portfolio by focusing on innovative technology sectors such as new industrialization and artificial intelligence [3]. Market Outlook - Recent improvements in the capital market are favorable for the company's project exits, which will accelerate the realization of returns from follow-on investments and performance compensation [3][4].